Naohiko Matsuo

Naohiko Matsuo joined OGT as a Director in 2025. He brings over 30 years of extensive experience in the diagnostics industry, with a distinguished track record in business strategy, business development and the management of R&D.

He began his career at Sysmex Corporation, where he served as Vice President of Product Development Group. He was then seconded as Chairperson of HYPHEN BioMed, a hemostasis reagent company in France, and later excelled as Executive Vice President of the Immunochemistry, Clinical Chemistry and Hemostasis (ICH) Business at Sysmex Corporation.

In 2023, he was appointed as an Executive Officer at Sysmex Corporation, taking the additional responsibility of Deputy Head of Business Strategy Segment.